RFCI vs. SBIO
RFCI (RiverFront Dynamic Core Income ETF) and SBIO (ALPS Medical Breakthroughs ETF) are both exchange-traded funds - RFCI is a Multisector Bonds fund actively managed by SS&C, while SBIO is a Health & Biotech Equities fund tracking the S-Network Medical Breakthroughs Index. RFCI is actively managed, while SBIO is passively managed. Over the past 10 years, RFCI returned 2.08%/yr vs 11.23%/yr for SBIO. At a 0.10 correlation, their price movements are largely independent. RFCI charges 0.54%/yr vs 0.50%/yr for SBIO.
Performance
RFCI vs. SBIO - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, RFCI achieves a 0.35% return, which is significantly lower than SBIO's 15.46% return. Over the past 10 years, RFCI has underperformed SBIO with an annualized return of 2.08%, while SBIO has yielded a comparatively higher 11.23% annualized return.
RFCI
- 1D
- 0.11%
- 1M
- 0.56%
- YTD
- 0.35%
- 6M
- 0.55%
- 1Y
- 3.92%
- 3Y*
- 4.63%
- 5Y*
- 1.21%
- 10Y*
- 2.08%
SBIO
- 1D
- 0.82%
- 1M
- 10.96%
- YTD
- 15.46%
- 6M
- 14.04%
- 1Y
- 97.46%
- 3Y*
- 24.04%
- 5Y*
- 4.26%
- 10Y*
- 11.23%
RFCI vs. SBIO - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
RFCI RiverFront Dynamic Core Income ETF | 0.35% | 6.85% | 2.64% | 5.97% | -9.27% | -1.48% | 6.48% | 8.69% | -1.30% | 3.14% |
SBIO ALPS Medical Breakthroughs ETF | 15.46% | 55.07% | 3.81% | 8.68% | -28.08% | -17.55% | 21.17% | 50.30% | -11.81% | 45.67% |
Correlation
The correlation between RFCI and SBIO is 0.25, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.25 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.25 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.22 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.10 |
Correlation (All Time) Calculated using the full available price history since Jun 17, 2016 | 0.10 |
The correlation between RFCI and SBIO shifts across timeframes, from 0.10 (10 years) to 0.25 (1 year), reflecting how their relationship changes across market environments.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
RFCI vs. SBIO — Risk / Return Rank
RFCI
SBIO
RFCI vs. SBIO - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for RiverFront Dynamic Core Income ETF (RFCI) and ALPS Medical Breakthroughs ETF (SBIO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| RFCI | SBIO | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -2.10 | ||
| Sortino ratioReturn per unit of downside risk | -2.47 | ||
| Omega ratioGain probability vs. loss probability | 1.20 | 1.48 | -0.29 |
| Calmar ratioReturn relative to maximum drawdown | 1.49 | 7.74 | -6.26 |
| Martin ratioReturn relative to average drawdown | 4.24 | 21.59 | -17.35 |
Loading charts...
Drawdowns
RFCI vs. SBIO - Drawdown Comparison
The maximum RFCI drawdown since its inception was -14.18%, smaller than the maximum SBIO drawdown of -63.06%. Use the drawdown chart below to compare losses from any high point for RFCI and SBIO.
Loading charts...
Drawdown Indicators
| RFCI | SBIO | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -14.18% | -63.06% | +48.88% |
Max Drawdown (1Y)Largest decline over 1 year | -2.65% | -12.66% | +10.01% |
Max Drawdown (3Y)Largest decline over 3 years | -5.10% | -42.44% | +37.34% |
Max Drawdown (5Y)Largest decline over 5 years | -13.46% | -53.10% | +39.64% |
Max Drawdown (10Y)Largest decline over 10 years | -14.18% | -63.06% | +48.88% |
Current DrawdownCurrent decline from peak | -1.16% | -3.55% | +2.39% |
Average DrawdownAverage peak-to-trough decline | -3.22% | -28.37% | +25.15% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 0.93% | 4.53% | -3.60% |
Volatility
RFCI vs. SBIO - Volatility Comparison
The current volatility for RiverFront Dynamic Core Income ETF (RFCI) is 1.00%, while ALPS Medical Breakthroughs ETF (SBIO) has a volatility of 11.06%. This indicates that RFCI experiences smaller price fluctuations and is considered to be less risky than SBIO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| RFCI | SBIO | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 1.00% | 11.06% | -10.06% |
Volatility (6M)Calculated over the trailing 6-month period | 2.69% | 23.78% | -21.09% |
Volatility (1Y)Calculated over the trailing 1-year period | 3.52% | 30.40% | -26.88% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 5.13% | 33.75% | -28.62% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 4.94% | 33.19% | -28.25% |
RFCI vs. SBIO - Expense Ratio Comparison
RFCI has a 0.54% expense ratio, which is higher than SBIO's 0.50% expense ratio.
Dividends
RFCI vs. SBIO - Dividend Comparison
RFCI's dividend yield for the trailing twelve months is around 4.55%, while SBIO has not paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
RFCI RiverFront Dynamic Core Income ETF | 4.55% | 4.55% | 4.30% | 3.55% | 2.26% | 3.45% | 2.04% | 2.66% | 2.76% | 2.03% | 1.97% |
SBIO ALPS Medical Breakthroughs ETF | 0.00% | 0.00% | 3.55% | 0.22% | 0.00% | 0.00% | 0.00% | 0.04% | 2.79% | 1.77% | 0.00% |
Frequently Asked Questions
RFCI and SBIO have a correlation of 0.25, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
SBIO has higher volatility (11.06%) compared to RFCI (1.00%). In terms of maximum drawdown, RFCI dropped -14.18% vs SBIO's -63.06%.
On 10-year performance, SBIO leads with 11.23% vs 2.08% for RFCI. On fees, SBIO is cheaper at 0.50% per year. On volatility, RFCI has been the lower-risk option at 1.00%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 10-year period, SBIO has performed better with a 11.23% return vs 2.08%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
SBIO is cheaper with a 0.50% expense ratio, compared with 0.54% for RFCI.
RFCI has the higher dividend yield at 4.55%, compared with 0.00% for SBIO.
RFCI is categorized as Multisector Bonds, while SBIO is Health & Biotech Equities. Their fees differ too: 0.54% for RFCI and 0.50% for SBIO.
SBIO currently has the higher Sharpe Ratio (3.22 vs 1.12), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for RFCI and SBIO
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer